Drugs / HPV L1 vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06686043 | Aug 2024 → Aug 2026 overdue | cervical carcinoma, human papillomavirus-related squamous cell carcinoma, vaginal carcinoma, vulvar carcinoma | Baylor College of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV L1 vaccine | “A Phase 2 Study of HPV L1 Vaccine in Combination With Imiquimod and Metformin in Cervical, Vaginal, and Vulvar Cancers” NCT06686043 ↗ |
| Modality | Vaccine | “An HPV vaccine will be injected into the tumor” NCT06686043 ↗ |